Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.

Cardiovascular drugs and therapy - 1 Jun 2021

Shaik Aleesha, Rosenson Robert S

Abstract excerpt

OBJECTIVE: Despite aggressive reduction of low-density lipoprotein cholesterol (LDL-C), there is a residual risk of cardiovascular disease (CVD). Hypertriglyceridemia is known to be associated with increased CVD risk, independently of LDL-C. Triglycerides are one component of the heterogenous class of triglyceride-rich lipoproteins (TGRLs). METHODS/RESULTS: Growing evidence from biology, epidemiology, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Chylomicrons
Share to Heart Disease Risk Factors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Inflammation Mediators

Share to Lipoprotein Lipase

Share to Lipoproteins

Share to Risk Reduction Behavior

Share to Triglycerides

Source

Identifiers

PMID: 33710501
DOI: 10.1007/s10557-021-07168-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.PMID 33710501Read ↗

Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.Semantic proximity Read ↗

Genetics of Triglycerides and the Risk of AtherosclerosisSemantic proximity Read ↗

Genetics of hypertriglyceridemia and atherosclerosisSemantic proximity Read ↗

A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular DiseaseSemantic proximity Read ↗

Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Semantic proximity Read ↗

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.Semantic proximity Read ↗

Genetic determinants of plasma triglycerides.Semantic proximity Read ↗

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic StudiesSemantic proximity Read ↗

Do triglyceride-lowering drugs decrease risk of cardiovascular disease?Semantic proximity Read ↗

Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.Semantic proximity Read ↗

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.Semantic proximity Read ↗

Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.